Literature DB >> 20406775

Fatal ammonia toxicity in an adult due to an undiagnosed urea cycle defect: under-recognition of ornithine transcarbamylase deficiency.

Vanessa R Thurlow1, Michelle Asafu-Adjaye, Stamatina Agalou, Yusof Rahman.   

Abstract

There is a lack of awareness of acutely presenting inborn errors of metabolism in adults, of which the X-linked urea cycle defect ornithine transcarbamylase (OTC) deficiency is an example, many comparatively mild mutations having been identified. In male hemizygotes clinical manifestations and age at presentation vary and depend on the mutation. In female heterozygotes the clinical spectrum depends on the extent to which the abnormal gene is expressed. Milder versions of the defect may not cause clear clinical symptoms and may remain unrecognized until the person is subjected to an unusually high nitrogen load when they develop severe hyperammonaemia. During acute episodes liver enzymes may be normal or only slightly elevated and occasionally accompanied by coagulopathy, but the key finding is hyperammonaemia. Boys with these milder forms may exhibit abnormal behaviour and be diagnosed with attention deficit hyperactivity disorder. This case illustrates how late presentation of OTC deficiency in a non-specialist centre can be difficult to differentiate from drug abuse, psychiatric illness or encephalopathy. Failure to measure blood ammonia in adults with unexplained key symptoms - particularly prolonged vomiting without diarrhoea and altered mental state/hallucinations, or to recognize the significance of elevated blood ammonia without evidence of liver decompensation can lead to delayed or missed diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20406775     DOI: 10.1258/acb.2010.009250

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  8 in total

1.  Case 1: Recurrent acute liver dysfunction in a 19-month-old boy.

Authors:  Yannis J Trakadis; Daniela M D'Agostino; Nancy E Braverman; Sébastien Lévesque; Veronique Morinville
Journal:  Paediatr Child Health       Date:  2012-05       Impact factor: 2.253

2.  Significant hepatic involvement in patients with ornithine transcarbamylase deficiency.

Authors:  Renata C Gallagher; Christina Lam; Derek Wong; Stephen Cederbaum; Ronald J Sokol
Journal:  J Pediatr       Date:  2014-01-30       Impact factor: 4.406

Review 3.  Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.

Authors:  Ljubica Caldovic; Iman Abdikarim; Sahas Narain; Mendel Tuchman; Hiroki Morizono
Journal:  J Genet Genomics       Date:  2015-05-19       Impact factor: 4.275

Review 4.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

Review 5.  Secondary psychosis induced by metabolic disorders.

Authors:  Olivier Bonnot; Paula M Herrera; Sylvie Tordjman; Mark Walterfang
Journal:  Front Neurosci       Date:  2015-05-19       Impact factor: 4.677

6.  Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment.

Authors:  Catia Cavicchi; Maria Donati; Rossella Parini; Miriam Rigoldi; Mauro Bernardi; Francesca Orfei; Nicolò Gentiloni Silveri; Aniello Colasante; Silvia Funghini; Serena Catarzi; Elisabetta Pasquini; Giancarlo la Marca; Sean Mooney; Renzo Guerrini; Amelia Morrone
Journal:  Orphanet J Rare Dis       Date:  2014-07-16       Impact factor: 4.123

Review 7.  Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review.

Authors:  Olivier Bonnot; Hans Hermann Klünemann; Frederic Sedel; Sylvie Tordjman; David Cohen; Mark Walterfang
Journal:  Orphanet J Rare Dis       Date:  2014-04-28       Impact factor: 4.123

8.  Cross-sectional observational study of 208 patients with non-classical urea cycle disorders.

Authors:  Corinne M Rüegger; Martin Lindner; Diana Ballhausen; Matthias R Baumgartner; Skadi Beblo; Anibh Das; Matthias Gautschi; Esther M Glahn; Sarah C Grünert; Julia Hennermann; Michel Hochuli; Martina Huemer; Daniela Karall; Stefan Kölker; Robin H Lachmann; Amelie Lotz-Havla; Dorothea Möslinger; Jean-Marc Nuoffer; Barbara Plecko; Frank Rutsch; René Santer; Ute Spiekerkoetter; Christian Staufner; Tamar Stricker; Frits A Wijburg; Monique Williams; Peter Burgard; Johannes Häberle
Journal:  J Inherit Metab Dis       Date:  2013-06-19       Impact factor: 4.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.